Hans E. Bishop

Other Washington, United States ·Founded 2021

Overview

Hans E. Bishop is a prominent figure in the biotechnology sector, recognized for his significant contributions as an executive and investor. He co-founded Altos Labs, a company dedicated to cellular rejuvenation programming to reverse disease, injury, and the disabilities that can occur throughout life. Under his leadership, Altos Labs has attracted substantial investment, focusing on advancing regenerative medicine and cellular therapies. Prior to his role at Altos Labs, Bishop served as the Chief Executive Officer of Juno Therapeutics, a company specializing in immunotherapies for cancer treatment. His tenure at Juno was marked by strategic growth and the development of innovative therapies. Before Juno, he held various leadership positions, including Executive Vice President and Chief Operating Officer at Dendreon, and President of Specialty Medicine at Bayer HealthCare. His extensive experience spans across multiple facets of the biotechnology and pharmaceutical industries. Bishop's investment approach is characterized by a focus on high-impact, innovative companies within the healthcare and biotechnology sectors. He seeks to identify and support ventures that have the potential to transform medical treatments and improve patient outcomes. His strategic vision and leadership have been instrumental in the success and growth of the companies he has been associated with, reflecting his commitment to advancing medical science and healthcare solutions.

Investment Focus

  • Innovative healthcare solutions
  • Strong management teams
  • Scalable business models
  • Potential for significant impact on patient care
  • Alignment with regenerative medicine and cellular therapy advancements

Portfolio Companies

Bayer HealthcareJuno TherapeuticsDendreonAltos Labs

Get the full list of 54,000+ investors

Hans E. Bishop and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Hans E. Bishop

What sectors does Hans E. Bishop invest in?

Hans E. Bishop invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Medical Research, and is based in Washington, United States. Hans E. Bishop is listed as a other in the ConnectSafely investor database.

What stage does Hans E. Bishop invest at?

Hans E. Bishop backs companies at Early Stage, Growth and Late Stage, writing cheques of 5M - 50M.

Which regions does Hans E. Bishop invest in?

Hans E. Bishop invests across United States, United Kingdom, Canada, Germany, Japan and Australia.

What companies has Hans E. Bishop invested in?

Hans E. Bishop's portfolio includes Bayer Healthcare, Juno Therapeutics, Dendreon and Altos Labs.

Last updated · Source: ConnectSafely investor database